Will Yakowicz is a Staff Writer at Forbes. He covers topics related to cannabis, gambling, and psychedelics, focusing on the business and regulatory aspects of the cannabis industry. Will's work has been featured in T-SPAN, RealClearMarkets, Forbes, and Forbes Australia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Will Yakowicz's coverage is predominantly focused on cannabis legalization, with a specific interest in legal policy regulation and government announcement. His articles often cite data to support his reporting.
Given this focus, Will may be receptive to pitches from experts who can provide insights into the legal, regulatory, and financial aspects of the cannabis industry in the United States. Additionally, sources who have access to valuable data or can provide analysis based on credible statistics might pique his interest.
Considering that he covers sports betting and gambling topics as well, professionals with expertise in these areas could also find success when reaching out to him for potential collaboration or commentary.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Kim Rivers, CEO of Florida-based Trulieve, was instrumental in getting the president to issue an executive order to reschedule marijuana. Now she is trying to build her $1.2 billion company into the Starbucks of weed.
By: Will Yakowicz
The Justice Department could officially reschedule marijuana as a Schedule III drug as soon as Wednesday, multiple outlets reported, removing it
By: Will Yakowicz
The Trump administration's acting attorney general Todd Blanche signed an order on Thursday reclassifying FDA-approved and state-licensed medical
Pre-rolls have overtaken flower as the best-selling category in the $30 billion cannabis industry. Companies like Jeeter and Stiiizy lead the way, but a five-year-old startup is on deck to score big.
Former Meta and Microsoft engineers Jun Sup Lee and Vince Ning built Nabis into the country’s biggest marijuana distributor, delivering $1.5 billion worth of weed to dispensaries every year.
Now that Vertanical's Exilby has been approved in Germany to treat chronic pain, Clemens Fischer, the pharma billionaire behind it, has set his sights on the U.S. market. ‘There is no plan B for me.'
By: Will Yakowicz
Beak & Skiff has been producing apples for more than a century, but its fifth-generation co-owner saw a lucrative growth opportunity in the $30 billion weed industry.
By: Will Yakowicz
A year after a deadly ICE raid on its massive cannabis farms, Glass House is preparing to trade on the New York Stock Exchange, harvest 1 million pounds of weed and export its product all over the world.
By: Will Yakowicz
A year after a deadly ICE raid on its massive cannabis farms and months after the Trump Administration reclassified medical marijuana, Glass House
By: Will Yakowicz
Once an elite lacrosse player, David Morrow took what he learned at Warrior Sports and built Lume into the biggest cannabis company in Michigan, with a plan to go national. “They're not ready for this knife fight.”
